0000899243-20-019906.txt : 20200721 0000899243-20-019906.hdr.sgml : 20200721 20200721195639 ACCESSION NUMBER: 0000899243-20-019906 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200721 FILED AS OF DATE: 20200721 DATE AS OF CHANGE: 20200721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Caffo Nathan CENTRAL INDEX KEY: 0001816992 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39386 FILM NUMBER: 201039980 MAIL ADDRESS: STREET 1: C/O ALX ONCOLOGY HOLDINGS INC. STREET 2: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC CENTRAL INDEX KEY: 0001810182 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850642577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650-466-7125 MAIL ADDRESS: STREET 1: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-21 0 0001810182 ALX ONCOLOGY HOLDINGS INC ALXO 0001816992 Caffo Nathan C/O ALX ONCOLOGY HOLDINGS INC. 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 0 1 0 0 Chief Business Officer Common Stock 2020-07-21 4 C 0 10529 A 11254 I See footnote Series B Convertible Preferred Stock 2020-07-21 4 C 0 10529 D Common Stock 10529 0 I See footnote Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date. Includes 725 shares of Common Stock issued as payment of accrued dividends upon conversion of the preferred stock on July 21, 2020. The shares are held of record by the reporting person's spouse. /s/ Peter Garcia, by power of attorney 2020-07-21